| P2093 | author name string | Jacques Belleville | |
| P2860 | cites work | Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits | Q24655522 |
| | Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group | Q28140891 |
| | Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease | Q28282436 |
| | Alcohol enhances oxysterol-induced apoptosis in human endothelial cells by a calcium-dependent mechanism | Q32085764 |
| | Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells | Q32117371 |
| | Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine | Q34062809 |
| | Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer | Q34336352 |
| | Wine, alcohol, platelets, and the French paradox for coronary heart disease | Q34538674 |
| | Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study | Q34726987 |
| | Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China | Q36242012 |
| | Alcohol consumption and blood pressure. Kaiser-Permanente Multiphasic Health Examination data | Q36788738 |
| | Effect of moderate dose of alcohol with evening meal on fibrinolytic factors | Q36884954 |
| | Mortality associated with moderate intakes of wine, beer, or spirits. | Q36903416 |
| | Effects of alcohol on lipoproteins in relation to coronary heart disease | Q40479999 |
| | High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function | Q40840454 |
| | Prospective study of alcohol consumption and risk of coronary disease in men. | Q41134811 |
| | Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity | Q41195905 |
| | Effects of Alcohol on Energy Metabolism and Body Weight Regulation: Is Alcohol a Risk Factor for Obesity? | Q41522733 |
| | Moderate alcohol intake and mortality. | Q41711434 |
| | Postterm delivery: a challenge for epidemiologic research | Q41721892 |
| | Effect of ethanol on platelet phospholipase A2 | Q42057506 |
| | Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990 | Q43613193 |
| | Development of tolerance to inhibitory effect of ethanol on endothelium-dependent vascular relaxation in ethanol-fed rats | Q44195642 |
| | Alcohol delays clearance of lipoproteins from the circulation | Q45719201 |
| | Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. | Q45984732 |
| | Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation | Q72495104 |
| | Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation | Q72582403 |
| | Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction | Q72623980 |
| | Inhibition of oxidation of low-density lipoprotein with red wine | Q72737412 |
| | Alcohol and coronary heart disease: a perspective from the British Regional Heart Study | Q72804660 |
| | Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure | Q72962790 |
| | Moderate beer consumption and the blood coagulation in patients with coronary artery disease | Q73093010 |
| | Does a glass of red wine improve endothelial function? | Q73301662 |
| | Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII | Q77829231 |
| | Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. | Q46018074 |
| | Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? | Q46117424 |
| | Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine | Q46132599 |
| | Does diet or alcohol explain the French paradox? | Q46934927 |
| | Effect of drinking pattern on plasma lipoproteins and body weight | Q47430497 |
| | Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol | Q47649514 |
| | Lipoprotein composition influences cholesteryl ester transfer in alcohol abusers | Q47793880 |
| | A controlled trial of the effects of pattern of alcohol intake on serum lipid levels in regular drinkers | Q47987286 |
| | Intake of beer, wine, and spirits and risk of stroke : the copenhagen city heart study. | Q50854957 |
| | Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. | Q50887170 |
| | Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease | Q50947414 |
| | Alcohol consumption had no beneficial effect on serum lipids in a substantial proportion of patients with primary hyperlipidemia. | Q51553195 |
| | Type of alcoholic beverage and risk of myocardial infarction. | Q51564825 |
| | Alcohol-free red wine enhances plasma antioxidant capacity in humans. | Q51569475 |
| | Wine: does the colour count? | Q51582262 |
| | Ethanol affects sympathetic cotransmission and endothelium-dependent relaxation in the rat. | Q52217669 |
| | Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group | Q52420764 |
| | Drinking habits and cardiovascular disease: the Framingham Study. | Q52706903 |
| | Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. | Q52883716 |
| | Alcohol consumption and mortality among women. | Q55064753 |
| | Cardiovascular risk factors and alcohol consumption in France and Northern Ireland | Q59660649 |
| | Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations | Q66904521 |
| | Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II: a controlled study | Q67239924 |
| | Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men | Q67266447 |
| | A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men | Q67899481 |
| | The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a) | Q67904214 |
| | Alcohol and mortality | Q68051325 |
| | Effect of a moderate alcohol intake on the lipoproteins of normotriglyceridemic obese subjects compared with normoponderal controls | Q68228304 |
| | Correlates of alcoholic beverage preference: traits of persons who choose wine, liquor or beer | Q68640760 |
| | Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study | Q69259416 |
| | Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects | Q69506501 |
| | Time-course, magnitude and nature of the changes induced in HDL by moderate alcohol intake in young non-drinking males | Q69564278 |
| | Relations of alcoholic beverage use to subsequent coronary artery disease hospitalization | Q69633287 |
| | Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease | Q69908116 |
| | Moderate alcohol and decreased cardiovascular mortality in an elderly cohort | Q70081637 |
| | Effect of smoking and dietary saturated fats on platelet functions in Scottish farmers | Q70085086 |
| | The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study | Q70327266 |
| | Relationship of alcohol consumption to changes in HDL-subfractions | Q70493545 |
| | Ethanol enhances de novo synthesis of high density lipoprotein cholesterol | Q70572166 |
| | High-density lipoprotein cholesterol and alcohol consumption in US white and black adults: data from NHANES II | Q70729277 |
| | Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins | Q71055882 |
| | Effect of dietary supplementation of red or white wine on human blood chemistry, hematology and coagulation: favorable effect of red wine on plasma high-density lipoprotein | Q71687228 |
| | Oxidative susceptibility of low-density lipoproteins--influence of regular alcohol use | Q71727612 |
| | Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators | Q72059248 |
| | A Remarkable Increase in High‐Density Lipoprotein‐Cholesterol by Alcohol Intake in a Homozygous Patient with Cholesteryl Ester Transfer Protein Deficiency | Q72107293 |
| | Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study | Q72157251 |
| | Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator | Q72342448 |
| P433 | issue | 2 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 173-177 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Nutrition | Q15762858 |
| P1476 | title | The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases | |
| P478 | volume | 18 | |